nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—UGT1A9—Irinotecan—hematologic cancer	0.0486	0.0544	CbGbCtD
Ketobemidone—CYP2B6—Thiotepa—hematologic cancer	0.0454	0.0508	CbGbCtD
Ketobemidone—PTGS1—Bortezomib—hematologic cancer	0.0441	0.0494	CbGbCtD
Ketobemidone—PTGS1—Thalidomide—hematologic cancer	0.0384	0.043	CbGbCtD
Ketobemidone—PTGS1—Ifosfamide—hematologic cancer	0.0338	0.0379	CbGbCtD
Ketobemidone—PTGS1—Imatinib—hematologic cancer	0.0323	0.0362	CbGbCtD
Ketobemidone—CYP2C9—Bexarotene—hematologic cancer	0.0289	0.0324	CbGbCtD
Ketobemidone—CYP2B6—Ifosfamide—hematologic cancer	0.0258	0.0288	CbGbCtD
Ketobemidone—CYP2C8—Bortezomib—hematologic cancer	0.0254	0.0285	CbGbCtD
Ketobemidone—CYP2C9—Idarubicin—hematologic cancer	0.024	0.0269	CbGbCtD
Ketobemidone—CYP2B6—Nilotinib—hematologic cancer	0.0224	0.025	CbGbCtD
Ketobemidone—CYP2C19—Bortezomib—hematologic cancer	0.0213	0.0239	CbGbCtD
Ketobemidone—CYP2C8—Ifosfamide—hematologic cancer	0.0195	0.0218	CbGbCtD
Ketobemidone—CYP2C19—Thalidomide—hematologic cancer	0.0186	0.0208	CbGbCtD
Ketobemidone—CYP2C9—Bortezomib—hematologic cancer	0.0177	0.0199	CbGbCtD
Ketobemidone—CYP2C19—Teniposide—hematologic cancer	0.0177	0.0199	CbGbCtD
Ketobemidone—CYP2C8—Nilotinib—hematologic cancer	0.0169	0.019	CbGbCtD
Ketobemidone—CYP3A4—Bexarotene—hematologic cancer	0.0168	0.0188	CbGbCtD
Ketobemidone—CYP2C19—Ifosfamide—hematologic cancer	0.0164	0.0183	CbGbCtD
Ketobemidone—PTGS1—Etoposide—hematologic cancer	0.0162	0.0181	CbGbCtD
Ketobemidone—CYP3A4—Lomustine—hematologic cancer	0.0156	0.0175	CbGbCtD
Ketobemidone—CYP3A4—Busulfan—hematologic cancer	0.0156	0.0175	CbGbCtD
Ketobemidone—CYP2C19—Imatinib—hematologic cancer	0.0156	0.0175	CbGbCtD
Ketobemidone—CYP2C9—Thalidomide—hematologic cancer	0.0155	0.0173	CbGbCtD
Ketobemidone—CYP2B6—Irinotecan—hematologic cancer	0.0154	0.0172	CbGbCtD
Ketobemidone—CYP2C9—Teniposide—hematologic cancer	0.0147	0.0165	CbGbCtD
Ketobemidone—CYP3A4—Thiotepa—hematologic cancer	0.0139	0.0156	CbGbCtD
Ketobemidone—CYP2C9—Ifosfamide—hematologic cancer	0.0136	0.0152	CbGbCtD
Ketobemidone—CYP2C9—Imatinib—hematologic cancer	0.013	0.0146	CbGbCtD
Ketobemidone—CYP2B6—Cisplatin—hematologic cancer	0.0125	0.014	CbGbCtD
Ketobemidone—CYP2C9—Nilotinib—hematologic cancer	0.0118	0.0132	CbGbCtD
Ketobemidone—CYP3A4—Methoxsalen—hematologic cancer	0.0108	0.0121	CbGbCtD
Ketobemidone—CYP3A4—Bortezomib—hematologic cancer	0.0103	0.0116	CbGbCtD
Ketobemidone—CYP2C19—Prednisone—hematologic cancer	0.0103	0.0115	CbGbCtD
Ketobemidone—CYP2B6—Dexamethasone—hematologic cancer	0.0101	0.0113	CbGbCtD
Ketobemidone—CYP3A4—Daunorubicin—hematologic cancer	0.00987	0.011	CbGbCtD
Ketobemidone—CYP2C8—Etoposide—hematologic cancer	0.00932	0.0104	CbGbCtD
Ketobemidone—CYP3A4—Cytarabine—hematologic cancer	0.0087	0.00975	CbGbCtD
Ketobemidone—CYP3A4—Teniposide—hematologic cancer	0.00857	0.0096	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—hematologic cancer	0.0084	0.0094	CbGbCtD
Ketobemidone—CYP3A4—Ifosfamide—hematologic cancer	0.00791	0.00886	CbGbCtD
Ketobemidone—CYP2C8—Dexamethasone—hematologic cancer	0.00767	0.00858	CbGbCtD
Ketobemidone—CYP3A4—Imatinib—hematologic cancer	0.00756	0.00846	CbGbCtD
Ketobemidone—CYP3A4—Ruxolitinib—hematologic cancer	0.00712	0.00797	CbGbCtD
Ketobemidone—CYP3A4—Nilotinib—hematologic cancer	0.00687	0.00769	CbGbCtD
Ketobemidone—CYP3A4—Vinorelbine—hematologic cancer	0.00681	0.00763	CbGbCtD
Ketobemidone—CYP2C9—Cisplatin—hematologic cancer	0.00662	0.00741	CbGbCtD
Ketobemidone—CYP2C19—Dexamethasone—hematologic cancer	0.00643	0.0072	CbGbCtD
Ketobemidone—CYP3A4—Triamcinolone—hematologic cancer	0.00623	0.00698	CbGbCtD
Ketobemidone—CYP3A4—Dasatinib—hematologic cancer	0.00607	0.0068	CbGbCtD
Ketobemidone—CYP3A4—Mitoxantrone—hematologic cancer	0.006	0.00671	CbGbCtD
Ketobemidone—CYP2C9—Dexamethasone—hematologic cancer	0.00535	0.00599	CbGbCtD
Ketobemidone—CYP3A4—Betamethasone—hematologic cancer	0.00534	0.00598	CbGbCtD
Ketobemidone—CYP3A4—Prednisolone—hematologic cancer	0.00527	0.00591	CbGbCtD
Ketobemidone—CYP3A4—Prednisone—hematologic cancer	0.00498	0.00558	CbGbCtD
Ketobemidone—CYP3A4—Irinotecan—hematologic cancer	0.00472	0.00529	CbGbCtD
Ketobemidone—CYP3A4—Vinblastine—hematologic cancer	0.0042	0.0047	CbGbCtD
Ketobemidone—CYP3A4—Vincristine—hematologic cancer	0.00413	0.00462	CbGbCtD
Ketobemidone—CYP3A4—Etoposide—hematologic cancer	0.00378	0.00423	CbGbCtD
Ketobemidone—CYP3A4—Dexamethasone—hematologic cancer	0.00311	0.00348	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—hematologic cancer	0.00258	0.00289	CbGbCtD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.9e-06	7.39e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MTOR—hematologic cancer	7.9e-06	7.38e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	7.9e-06	7.38e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BAD—hematologic cancer	7.89e-06	7.37e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	7.89e-06	7.37e-05	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	7.87e-06	7.36e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NCOR1—hematologic cancer	7.83e-06	7.31e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTM1—hematologic cancer	7.83e-06	7.31e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	7.81e-06	7.3e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.8e-06	7.29e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	7.78e-06	7.27e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3R1—hematologic cancer	7.76e-06	7.25e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CA9—hematologic cancer	7.75e-06	7.24e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ACP5—hematologic cancer	7.75e-06	7.24e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CD44—hematologic cancer	7.72e-06	7.21e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NQO1—hematologic cancer	7.72e-06	7.21e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CD80—hematologic cancer	7.65e-06	7.15e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.64e-06	7.14e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	7.64e-06	7.14e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KIT—hematologic cancer	7.64e-06	7.14e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	7.64e-06	7.14e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CG—hematologic cancer	7.62e-06	7.12e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FGF2—hematologic cancer	7.61e-06	7.11e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.56e-06	7.06e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	7.54e-06	7.05e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	7.51e-06	7.01e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	7.5e-06	7.01e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.46e-06	6.97e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	7.41e-06	6.93e-05	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	7.33e-06	6.85e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	7.32e-06	6.84e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.31e-06	6.84e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYCS—hematologic cancer	7.3e-06	6.82e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—JAK2—hematologic cancer	7.29e-06	6.82e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—IDH1—hematologic cancer	7.28e-06	6.81e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CREB1—hematologic cancer	7.27e-06	6.8e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CASP3—hematologic cancer	7.27e-06	6.79e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	7.26e-06	6.78e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—hematologic cancer	7.25e-06	6.78e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—hematologic cancer	7.22e-06	6.75e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTP1—hematologic cancer	7.21e-06	6.74e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.2e-06	6.73e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.2e-06	6.73e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TXN—hematologic cancer	7.2e-06	6.73e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BRAF—hematologic cancer	7.18e-06	6.71e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CB—hematologic cancer	7.16e-06	6.69e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	7.15e-06	6.68e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MDM2—hematologic cancer	7.12e-06	6.65e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL2—hematologic cancer	7.12e-06	6.65e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6R—hematologic cancer	7.09e-06	6.63e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	7.08e-06	6.62e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—hematologic cancer	7.07e-06	6.61e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CREBBP—hematologic cancer	7.06e-06	6.6e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—JUN—hematologic cancer	7.06e-06	6.59e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.05e-06	6.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NQO1—hematologic cancer	7.04e-06	6.57e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CD44—hematologic cancer	7.04e-06	6.57e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.98e-06	6.52e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MTOR—hematologic cancer	6.93e-06	6.47e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	6.93e-06	6.47e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MTHFR—hematologic cancer	6.92e-06	6.46e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.89e-06	6.44e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	6.84e-06	6.39e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTEN—hematologic cancer	6.83e-06	6.38e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ABCB1—hematologic cancer	6.83e-06	6.38e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.77e-06	6.33e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	6.76e-06	6.32e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	6.72e-06	6.28e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CD—hematologic cancer	6.7e-06	6.26e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	6.68e-06	6.24e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	6.66e-06	6.22e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYCS—hematologic cancer	6.66e-06	6.22e-05	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.65e-06	6.22e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTM1—hematologic cancer	6.63e-06	6.19e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NCOR1—hematologic cancer	6.63e-06	6.19e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	6.62e-06	6.18e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	6.61e-06	6.18e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ALB—hematologic cancer	6.61e-06	6.18e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.59e-06	6.15e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.59e-06	6.15e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	6.58e-06	6.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.53e-06	6.1e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EP300—hematologic cancer	6.51e-06	6.08e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	6.5e-06	6.07e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTP1—hematologic cancer	6.44e-06	6.01e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FGF2—hematologic cancer	6.43e-06	6.01e-05	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	6.43e-06	6.01e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.42e-06	6e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CASP3—hematologic cancer	6.37e-06	5.95e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—hematologic cancer	6.36e-06	5.94e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	6.34e-06	5.93e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SRC—hematologic cancer	6.33e-06	5.92e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—hematologic cancer	6.33e-06	5.91e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3R1—hematologic cancer	6.32e-06	5.91e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.23e-06	5.82e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NUP98—hematologic cancer	6.22e-06	5.81e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—hematologic cancer	6.2e-06	5.8e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—JUN—hematologic cancer	6.19e-06	5.78e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTEN—hematologic cancer	6.19e-06	5.78e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	6.17e-06	5.76e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—JAK2—hematologic cancer	6.16e-06	5.76e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—hematologic cancer	6.1e-06	5.7e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.09e-06	5.69e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NRAS—hematologic cancer	6.09e-06	5.69e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	6.04e-06	5.65e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.03e-06	5.64e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.03e-06	5.64e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MDM2—hematologic cancer	6.02e-06	5.62e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	6e-06	5.61e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NUP214—hematologic cancer	5.99e-06	5.6e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTEN—hematologic cancer	5.99e-06	5.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.95e-06	5.56e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NCOR1—hematologic cancer	5.91e-06	5.53e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTM1—hematologic cancer	5.91e-06	5.53e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—EP300—hematologic cancer	5.9e-06	5.51e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTR—hematologic cancer	5.87e-06	5.49e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.87e-06	5.49e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTP1—hematologic cancer	5.87e-06	5.48e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MTHFR—hematologic cancer	5.86e-06	5.47e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	5.86e-06	5.47e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MTOR—hematologic cancer	5.85e-06	5.47e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	5.85e-06	5.47e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	5.84e-06	5.46e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CB—hematologic cancer	5.84e-06	5.45e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	5.83e-06	5.45e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CG—hematologic cancer	5.81e-06	5.43e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ENO2—hematologic cancer	5.76e-06	5.38e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EP300—hematologic cancer	5.71e-06	5.33e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.68e-06	5.31e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—hematologic cancer	5.67e-06	5.3e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	5.66e-06	5.29e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	5.59e-06	5.22e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.58e-06	5.22e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.55e-06	5.19e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SRC—hematologic cancer	5.55e-06	5.19e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	5.49e-06	5.13e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SDC1—hematologic cancer	5.46e-06	5.1e-05	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	5.43e-06	5.08e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	5.41e-06	5.05e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.39e-06	5.04e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.39e-06	5.04e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CREBBP—hematologic cancer	5.39e-06	5.04e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CASP3—hematologic cancer	5.38e-06	5.03e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—hematologic cancer	5.38e-06	5.02e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—hematologic cancer	5.35e-06	5e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—hematologic cancer	5.35e-06	5e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NRAS—hematologic cancer	5.34e-06	4.99e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—hematologic cancer	5.24e-06	4.9e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—hematologic cancer	5.24e-06	4.9e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—JUN—hematologic cancer	5.23e-06	4.89e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.23e-06	4.88e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.16e-06	4.82e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	5.11e-06	4.78e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CD—hematologic cancer	5.11e-06	4.77e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	5.07e-06	4.74e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTEN—hematologic cancer	5.06e-06	4.73e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALB—hematologic cancer	5.04e-06	4.71e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTEN—hematologic cancer	5.04e-06	4.71e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—hematologic cancer	4.97e-06	4.65e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	4.96e-06	4.64e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	4.95e-06	4.62e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	4.94e-06	4.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	4.92e-06	4.6e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EP300—hematologic cancer	4.82e-06	4.51e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3R1—hematologic cancer	4.82e-06	4.51e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	4.82e-06	4.5e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—EP300—hematologic cancer	4.81e-06	4.49e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.77e-06	4.45e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SRC—hematologic cancer	4.69e-06	4.38e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—hematologic cancer	4.66e-06	4.35e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NQO1—hematologic cancer	4.64e-06	4.34e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CD44—hematologic cancer	4.64e-06	4.34e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.61e-06	4.3e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—hematologic cancer	4.6e-06	4.29e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	4.57e-06	4.27e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CREBBP—hematologic cancer	4.56e-06	4.26e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—hematologic cancer	4.52e-06	4.23e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NRAS—hematologic cancer	4.51e-06	4.22e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HRAS—hematologic cancer	4.46e-06	4.16e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CB—hematologic cancer	4.45e-06	4.16e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.39e-06	4.1e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYCS—hematologic cancer	4.39e-06	4.1e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—hematologic cancer	4.36e-06	4.08e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.36e-06	4.08e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	4.33e-06	4.04e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	4.32e-06	4.04e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALB—hematologic cancer	4.27e-06	3.99e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—hematologic cancer	4.26e-06	3.98e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	4.22e-06	3.95e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—hematologic cancer	4.2e-06	3.93e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.2e-06	3.92e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	4.19e-06	3.92e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—hematologic cancer	4.08e-06	3.82e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	4.08e-06	3.82e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.07e-06	3.8e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4e-06	3.74e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—hematologic cancer	3.93e-06	3.68e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HRAS—hematologic cancer	3.91e-06	3.65e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—hematologic cancer	3.88e-06	3.63e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.87e-06	3.62e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.86e-06	3.61e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTEN—hematologic cancer	3.85e-06	3.6e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALB—hematologic cancer	3.81e-06	3.56e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	3.77e-06	3.52e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—hematologic cancer	3.74e-06	3.49e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.71e-06	3.47e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—EP300—hematologic cancer	3.67e-06	3.43e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.66e-06	3.42e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.65e-06	3.41e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	3.57e-06	3.33e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—hematologic cancer	3.57e-06	3.33e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—hematologic cancer	3.56e-06	3.32e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.56e-06	3.32e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.56e-06	3.32e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.52e-06	3.29e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALB—hematologic cancer	3.48e-06	3.25e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—hematologic cancer	3.45e-06	3.23e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—hematologic cancer	3.45e-06	3.22e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.37e-06	3.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.32e-06	3.11e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HRAS—hematologic cancer	3.3e-06	3.09e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTEN—hematologic cancer	3.26e-06	3.04e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—hematologic cancer	3.16e-06	2.95e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.14e-06	2.94e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—EP300—hematologic cancer	3.11e-06	2.9e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.07e-06	2.87e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—hematologic cancer	2.92e-06	2.72e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTEN—hematologic cancer	2.91e-06	2.72e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—hematologic cancer	2.91e-06	2.72e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—EP300—hematologic cancer	2.77e-06	2.59e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—hematologic cancer	2.71e-06	2.54e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTEN—hematologic cancer	2.65e-06	2.48e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.64e-06	2.47e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—EP300—hematologic cancer	2.53e-06	2.36e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.45e-06	2.29e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.32e-06	2.17e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.3e-06	2.15e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALB—hematologic cancer	2.29e-06	2.14e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—hematologic cancer	2.22e-06	2.07e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.19e-06	2.05e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.05e-06	1.92e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.02e-06	1.89e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—hematologic cancer	1.88e-06	1.75e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.87e-06	1.75e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.75e-06	1.63e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—hematologic cancer	1.68e-06	1.57e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—EP300—hematologic cancer	1.67e-06	1.56e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—hematologic cancer	1.53e-06	1.43e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.23e-06	1.15e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.01e-06	9.42e-06	CbGpPWpGaD
